Effective Anti-Bribery Compliance as a Competitive Advantage for Doing Business in India
18 November 2014
Foley and the U.S. Consul General in Mumbai, Thomas Vajda, co-hosted an evening reception at the American Consulate in Mumbai for U.S. businesses operating in India.
Partner David Simon and Senior Counsel John Turlais, along with MZM Legal, served on a panel discussion titled “Effective Anti-Bribery Compliance as a Competitive Advantage for Doing Business in India.”
Pictured left to right in accompanying photo: David Simon, Foley & Lardner LLP; Shebir Panag, Associate – Criminal Compliance, MZM Legal; Dr. Karl Sidhu, Partner, Roxin Rechtsanwälte LLP; Zulfiquar Memon, Managing Partner, MZM Legal; Thomas Waidja, U.S. Consul General; John Turlais, Foley & Lardner LLP
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.